Development of a new reagent for endoscopic ultrasound-guided celiac plexus neurolysis and tumor ablation therapy
Kazuo Hara, Kenji Yamao, Nobumasa Mizuno, Susumu Hijioka, Hiroshi Imaoka, Masahiro Tajika, Tutomu Tanaka, Makoto Ishihara, Takamitu Sato, Nozomi Okuno, Nobuhiro Hieda, Tukasa Yoshida, Yasumasa Niwa
Abstract
Background
Both endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) and tumor ablation using ethanol are very common procedures, and the utility of these therapies has already been reported in prominent journals. However, their effectiveness appears temporary and insufficient, especially EUS-CPN. We therefore have to consider new reagents for improving the results. The present study examined the best concentration of ethanol and povidone iodine mixed with atelocollagen for more effective therapies.
Methods
The effects of the new reagents were confirmed in three live pigs. At first, we injected three kinds of reagents (including indigo carmine) in three separate areas of para-aortic tissue under EUS guidance in one pig. At more than 4 hours after injection, we checked ethanol injection sites after dissection. In next study, we performed EUS-guided injection of a total of six kinds of reagents (two kinds of ethanol, three kinds of povidone iodine, and control atelocollagen) into the livers of two living pigs. After 2 weeks, we examined tissue damage to the liver in the two pigs.
Results
The 75% ethanol (absolute ethanol 3.75 mL + 1% atelocollagen 1.25 mL + a very small amount of indigo carmine) was seen like blue gel, and still remained in the para-aortic tissue. Brownish areas of povidone iodine mixed with 3% atelocollagen exhibited clear, regular borders with greatly reduced infiltration into surrounding tissue compared to others.
Conclusion
We concluded that 75% ethanol mixed with 1% atelocollagen appears optimal for EUS-CPN. Povidone iodine mixed with 3% atelocollagen may be suitable for small tumor ablation therapy.
Introduction
Interventional endoscopic ultrasound (EUS), including EUS-guided fine needle aspiration, has recently become popular. In particular, EUS-guided drainage has been developed as an alternative to percutaneous and surgical approaches.1–3 The usefulness of EUS-guided biliary drainage, EUS-guided gallbladder drainage, EUS-guided drainage of pancreatic fluid collections, EUS-guided pancreatic duct drainage, and EUS-guided drainage of abdominal and pelvic collections have already been reported. Moreover, the utility of EUS-guided injection of various materials has also been described.4–8 Above all, EUS-guided tumor ablation,9–13 EUS-guided celiac plexus neurolysis (EUS-CPN), celiac plexus block, and celiac ganglion neurolysis (EUS-CGN) are expected to show a high degree of clinical usefulness.14–18 EUS-CPN is well established as an alternative method for providing pain relief and reducing narcotic use, and has become quite popular because of the technical simplicity and safety. EUS-CPN has been assessed with a high level of evidence in the literature, and some papers have reported EUS-CGN as highly effective for pain relief compared to EUS-CPN. The effectiveness of EUS-CPN for pain relief is clear clinically, but remains insufficient and temporary. Patients need more effective options than pure ethanol injection. Injected ethanol infiltrates and rapidly spreads into surrounding tissue, requiring a relatively large amount for effective treatment. If the viscosity of the injected ethanol could be increased, effectiveness might also improve.
This study sought to identify a more effective method for CPN and tumor ablation therapy using ethanol and povidone iodine. We selected atelocollagen to increase the viscosity of ethanol and povidone iodine, as a well-known disinfectant that can be used even in patients who are allergic to ethanol. Both ethanol and povidone iodine are inexpensive and widely available around the world. We hoped to increase the clinical efficacy of their use for patients with this study.
Methods
Protocol 1
We performed EUS-guided injection of three kinds of ethanol into para-aortic tissue in a sedated pig. At more than 4 hours after injection, we checked ethanol injection sites after dissection. A blue area of indigo carmine staining would be apparent if the injected ethanol remained in place.
Three concentrations of ethanol
99% ethanol: absolute ethanol 5 mL + a very small amount of indigo carmine
90% ethanol: absolute ethanol 4.5 mL + 1% atelocollagen 0.5 mL + a very small amount of indigo carmine
75% ethanol: absolute ethanol 3.75 mL + 1% atelocollagen 1.25 mL + a very small amount of indigo carmine
Protocol 2
We performed EUS-guided injection of a total of six kinds of reagents (two kinds of ethanol, three kinds of povidone iodine, and control atelocollagen) into the livers of two living pigs. After 2 weeks, we examined tissue damage to the liver in the two pigs. H&E staining of resected specimens was performed to evaluate tissue damage.
Six kinds of reagents
99% ethanol: absolute ethanol 3 mL
75% ethanol: absolute ethanol 2.25 mL + 1% atelocollagen 0.75 mL
10% povidone iodine 3 mL
1% povidone iodine: 10% povidone iodine 0.3 mL + 1% atelocollagen 0.75 mL + saline 1.95 mL
1% povidone iodine: 10% povidone iodine 0.3 mL + 3% atelocollagen 0.75 mL + saline 1.95 mL
Control: 1% atelocollagen 3 mL
Results
Protocol 1
We injected three kinds of reagents (including indigo carmine) in three separate areas of para-aortic tissue under EUS guidance (Fig. 1A). We can see the blue area of reagent 3 (75% ethanol: absolute ethanol 3.75 mL + 1% atelocollagen 1.25 mL + very small amount of indigo carmine) in the para-aortic tissue shown in Fig. 1B. Only reagent 3 was seen like blue gel, and still remained in place. Neither reagent 1 nor 2 was seen at the injection site at all.
Protocol 2
We made another two kinds of reagents (75% ethanol: absolute ethanol 2.25 mL + 3% atelocollagen 0.75 mL; 5% povidone iodine: 10% povidone iodine 1.5 mL + 3% atelocollagen 1.5 mL) as shown in Fig. 2. Ethanol plus 3% atelocollagen congeals easily, and so cannot be used, as shown in Fig. 2A. Conversely, 5% povidone iodine using 3% atelocollagen also becomes a hard gel that is difficult to aspirate and inject (Fig. 2B). Fig. 3 shows resected liver specimens from the two pigs. H&E staining shows the cytotoxic effects of the injected reagents (Fig. 4). As reagents 1 to 3 showed strong cytotoxic effects, we could not identify any viable cells in the injected area (Fig. 4A–4C). We also confirmed inflammation and infiltration into tissue surround the injected area by reagents 1 to 3 (Fig. 3A–3C, 4A–4C). However, viscosity of reagents 4 and 5 were high, resulting in round, brownish areas in the specimens (Fig. 3D, 3E). Both brownish areas exhibited clear, regular borders with greatly reduced infiltration into surrounding tissue compared to reagents 1 to 3. Cell death was seen only in the injected area, not in surrounding tissue (Fig. 4D, 4E). These findings were seen more with reagent 5 than with reagent 4. Only injected atelocollagen (reagent 6) showed no cytotoxicity for liver tissue (Fig. 4F).
Discussion
In case of EUS-CPN or tumor ablation therapy, pure ethanol is frequently used in clinical situations.14–18 Pure ethanol is safe, cheap, easy to get, and strongly cytotoxic. Ethanol injection therapies have thus become so commonplace around the world. However, ethanol is a liquid and easily infiltrates into surrounding tissue. After injection, ethanol rapidly percolates out and local cytotoxic effects are decreased. If the viscosity of the injected ethanol could be increased, ethanol would remain in the target area, and clinical effects would presumably be increased and last longer. We selected atelocollagen to increase viscosity. Atelocollagen is a type 1 collagen derived from the dermis of cows. Atelocollagen shows low antigenicity and high biocompatibility,19 and has seen use in a variety of applications. As another important point, some Japanese are allergic to ethanol, so new reagents are needed that are safe, cheap, easily obtained, and strongly cytotoxic. Finally, we selected povidone iodine. Protocol 1 examined the viscosity and penetration of different concentrations of ethanol mixed with atelocollagen. We could see the blue area of indigo carmine only with reagent 3 (75% ethanol: absolute ethanol 3.75 mL + 1% atelocollagen 1.25 mL + very small amount of indigo carmine). Because a high concentration of ethanol easily and rapidly percolates through tissues, we could not confirm blue areas of indigo carmine with reagents 1 and 2. If the concentration of ethanol is less than 75%, the cytotoxic effects will be decreased. Finally, we concluded that viscosity and stagnation were best for reagent 3 in this study. In protocol 2, we examined the cytotoxic effects of different concentrations of ethanol and povidone iodine. Degree of cytotoxicity was similar in reagents 1 to 3. Infiltration into surrounding tissue was strong, so the border of the injected area was irregular and unclear. In contrast, both reagents 4 and 5 (povidone iodine + atelocollagen) were only seen in the injected area. The borders of the injected areas for both reagents 4 and 5 were clear and regular. The influence of injected reagents 4 and 5 on surrounding tissue was weak. According to the results of protocols 1 and 2, we conclude that the cytotoxic effects, infiltration into surrounding tissue, and stagnation with reagent 3 were the best for EUS-CPN. Low infiltration into surrounding tissue and high viscosity and high stagnation with reagent 5 were considered the best for tumor ablation therapy. We think that EUS-guided fine needle injection for pancreatic neuroendocrine using reagent 5 should be safer and more effective than that using ethanol. We now have to confirm the safety and efficacy of this approach for humans in clinical trials.
In conclusion, we investigated the optimal concentrations of ethanol and povidone iodine using atelocollagen for EUS-CPN and tumor ablation therapy. For EUS-CPN, 75% ethanol mixed with 1% atelocollagen appears best. Povidone iodine mixed with 3% atelocollagen may be suitable for small tumor ablation therapy. Confirmation of the clinical usefulness of these methods in prospective trials is awaited.
Acknowledgments
This study is a collaboration with Boston Scientific.
Article information
Articles from Gastrointestinal Intervention are provided here courtesy of Gastrointestinal Intervention
References
- Hara K, Yamao K, Hijioka S, Mizuno N, Imaoka H, Tajika M. Prospective clinical study
of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent
placement using a forward-viewing echoendoscope. Endoscopy. 2013;45:392-6.
- Yamao K, Hara K, Mizuno N, Hijioka S, Imaoka H, Bhatia V. Endoscopic ultrasound-guided
choledochoduodenostomy for malignant lower biliary tract obstruction. Gastrointest Endosc Clin N Am. 2012;22:Array-69.
- Hara K, Yamao K, Niwa Y, Sawaki A, Mizuno N, Hijioka S. Prospective clinical study
of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction.
Am J Gastroenterol. 2011;106:1239-45.
- Hecht JR, Farrell JJ, Senzer N, Nemunaitis J, Rosemurgy A, Chung T. EUS or percutaneously
guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line
treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75:332-8.
- Hanna N, Ohana P, Konikoff FM, Leichtmann G, Hubert A, Appelbaum L. Phase 1/2a, dose-escalation,
safety, pharmacokinetic and preliminary efficacy study of intratumoral administration
of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther. 2012;19:374-81.
- Chang KJ, Lee JG, Holcombe RF, Kuo J, Muthusamy R, Wu ML. Endoscopic ultrasound delivery
of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol. 2008;5:107-11.
- Irisawa A, Takagi T, Kanazawa M, Ogata T, Sato Y, Takenoshita S. Endoscopic ultrasound-guided
fine-needle injection of immature dendritic cells into advanced pancreatic cancer
refractory to gemcitabine: a pilot study. Pancreas. 2007;35:189-90.
- Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM. A phase I/II trial
of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine
in unresectable pancreatic carcinoma. Clin Cancer Res. 2003;9:555-61.
- Vleggaar FP, Bij de Vaate EA, Valk GD, Leguit RJ, Siersema PD. Endoscopic ultrasound-guided
ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy. 2011;43:E328-9.
- Muscatiello N, Nacchiero M, Della Valle N, Di Terlizzi F, Verderosa G, Salcuni A.
Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic
ultrasound. Endoscopy. 2008;40:E83.
- Artifon EL, Lucon AM, Sakai P, Gerhardt R, Srougi M, Takagaki T. EUS-guided alcohol
ablation of left adrenal metastasis from non-small-cell lung carcinoma. Gastrointest Endosc. 2007;66:1201-5.
- Jürgensen C, Schuppan D, Neser F, Ernstberger J, Junghans U, Stölzel U. EUS-guided
alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63:1059-62.
- Barclay RL, Perez-Miranda M, Giovannini M. EUS-guided treatment of a solid hepatic
metastasis. Gastrointest Endosc. 2002;55:266-70.
- Doi S, Yasuda I, Kawakami H, Hayashi T, Hisai H, Irisawa A. Endoscopic ultrasound-guided
celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial.
Endoscopy. 2013;45:362-9.
- Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled
trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain
progression in patients with newly diagnosed, painful, inoperable pancreatic cancer.
J Clin Oncol. 2011;29:3541-6.
- Ascunce G, Ribeiro A, Reis I, Rocha-Lima C, Sleeman D, Merchan J. EUS visualization
and direct celiac ganglia neurolysis predicts better pain relief in patients with
pancreatic malignancy (with video). Gastrointest Endosc. 2011;73:267-74.
- Sakamoto H, Kitano M, Kamata K, Komaki T, Imai H, Chikugo T. EUS-guided broad plexus
neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599-606.
- Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided
celiac plexus block or neurolysis: a comparative study of short-term effectiveness.
Am J Gastroenterol. 2009;104:326-9.
- Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation.
Plast Reconstr Surg. 1977;60:398-405.
